In 2014, a paper was published in the medical journal PLoS One by WD Finkle et al. titled “Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.” studied the risk for heart attack suffered by users of testosterone therapy.

The authors state “An association between testosterone therapy (TT) and cardiovascular disease has been reported and TT use is increasing rapidly” and explain their study, writing “We conducted a cohort study of the risk of acute non-fatal myocardial infarction (MI) following an initial TT prescription (N = 55,593) in a large health-care database. We compared the incidence rate of MI in the 90 days following the initial prescription (post-prescription interval) with the rate in the one year prior to the initial prescription (pre-prescription interval) (post/pre).”

Overall, the risk for heart attack was 36% greater in men who used testosterone therapy.  In men over 65 years old, the risk for heart attack was 219% higher than for nonusers.  Men who used testosterone therapy under 55 years of age were found to be relatively safe, but men who were over 75 faced a risk for heart attack elevated by 343% compared to same-age nonusers.  In general, higher risk for heart attack in men under 65 was confined to those with history of heart disease.

Due to the fact that many men have used testosterone therapy such as Androgel unaware of the risk for heart attack associated with these products, a number of Androgel lawsuits have been filed.  If you or a loved one used Androgel and suffered heart attack or stroke, you too may be entitled to significant financial compensation from the manufacturer.  For a free, no-obligation case consultation, contact our team of Androgel lawyers at the information provided below.  We have the experience, resources, and skills required to win the compensation you deserve.

(855) 452 – 5529